Compare RGC & EPAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGC | EPAM |
|---|---|---|
| Founded | 2014 | 1993 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 7.0B |
| IPO Year | 2020 | 2011 |
| Metric | RGC | EPAM |
|---|---|---|
| Price | $28.89 | $112.68 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $196.21 |
| AVG Volume (30 Days) | 100.6K | ★ 1.3M |
| Earning Date | 10-31-2025 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.72 |
| Revenue | N/A | ★ $1,450,448,000.00 |
| Revenue This Year | N/A | $8.30 |
| Revenue Next Year | N/A | $7.17 |
| P/E Ratio | ★ N/A | $16.88 |
| Revenue Growth | N/A | ★ 25.02 |
| 52 Week Low | $9.39 | $109.70 |
| 52 Week High | $950.00 | $222.53 |
| Indicator | RGC | EPAM |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 27.08 |
| Support Level | $21.81 | N/A |
| Resistance Level | $33.50 | $135.00 |
| Average True Range (ATR) | 2.01 | 4.69 |
| MACD | -0.10 | -0.90 |
| Stochastic Oscillator | 39.91 | 11.78 |
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
EPAM Systems is a global IT services firm with a focus on platform engineering, software development, and consulting services. The company used to host large engineer bases in Ukraine, Belarus, and Russia, but it now delivers from various locations across different continents. EPAM's largest market is North America, which represents approximately 60% of revenue.